Changes in monocytic expression of aminopeptidase N/CD13 after major trauma

Clinical and Experimental Immunology

Volumn 134, Issue 3, 2003, Pages 491-496

  Huschak, G ^a   Zur Nieden, K ^a   Stuttmann, R ^a   Riemann, D ^b  

^a BG Kliniken   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

CD13; HLA DR; Intensive care medicine; Major trauma; Monocytes

Indexed keywords

AMINOPEPTIDASE; HLA DR ANTIGEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ENZYME; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; PHYCOERYTHRIN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INJURY; INJURY SCALE; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD13; CASE-CONTROL STUDIES; CELLS, CULTURED; CRANIOCEREBRAL TRAUMA; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HLA-DR ANTIGENS; HUMANS; INJURY SEVERITY SCORE; INTENSIVE CARE; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MULTIPLE TRAUMA; NEUTROPHILS; PROSPECTIVE STUDIES;

EID: 0348012898     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02302.x     Document Type: Article

References (34)

1. O'Mahony JB, Palder SB, Wood JJ et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24:869-75.
2. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr. Depressed Interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123:1309-12.
3. Faist E, Mewes A, Strasser T et al. Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-92.
4. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-7.
5. Riemann D, Kehlen A, Langner J. CD13 - not just a marker in leukemia typing. Immunol Today 1999; 20:83-8.
6. Laouar A, Wietzerbin J, Bauvois B. Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid. Int Immunol 1993; 5:965-73.
7. Koch AE, Burrows JC, Skoutelis A et al. Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages. Am J Pathol 1991; 138:165-73.
8. Van Hal PT, Hopstaken-Broos JP, Wijkhuijs JM, Te Velde AA, Figdor CG, Hoogsteden HC. Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. J Immunol 1992; 149:1395-401.
9. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 1994; 39:230-42.
10. Larsen SL, Pedersen LO, Buus S, Stryhn A. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 1996; 184:183-9.
11. Barrett AJ. Membrane alanyl aminopeptidase. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of proteolytic enzymes. London: Academic Press, 1998:996-1000.
12. Menrad A, Speicher D, Wacker J, Herlyn M. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 1993; 53:1450-5.
13. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983; 70:29-31.
14. Volk HD. Immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 2002; 6:279-81.
15. Rainer TH, Ng MH, Lam NY, Chan TY, Cocks RA. Role of monocyte 1-selectin in the development of post-traumatic organ failure. Resuscitation 2001; 51:139-49.
16. Riemann D, Kehlen A, Thiele K, Loehn M, Langner J. Induction of aminopeptidase N/CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages. J Immunol 1997; 158:3425-32.
17. Turner AJ. Membrane alanyl aminopeptidase. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of proteolytic enzymes. London: Academic Press, 1998:996-1000.
18. Weber M, Uguccioni M, Baggiolini M, Clark-Lewis I, Dahinden CA. Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 1996; 183:681-5.
19. Navarrete-Santos A, Langner J, Herrmann M, Riemann D. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol 2000; 201:22-32.
20. Nussler AK, Wittel UA, Nussler NC, Beger HG. Leukocytes, the Janus cells in inflammatory disease. Langenbecks Arch Surg 1999; 384:222-32.
21. Balog T, Marotti T, Abramic M, Svoboda-Beusen I, Hrsak I. The role of aminopeptidase N in Met-enkephalin modulated superoxide anion release. Immunopharmacology 1999; 41:11-20.
22. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 1993; 82:1052-70.
23. Ziaber J, Pasnik J, Baj Z, Pokoca L, Chmielewski H, Tchorzewski H. The immunoregulatory abilities of polymorphonuclear neutrophils in the course of multiple sclerosis. Med Inflamm 1998; 7:335-8.
24. Pannu KK, Joe ET, Iyer SB. Performance evaluation of QuantiBRITE phycoerythrin beads. Cytometry 2001; 45:250-8.
25. Lenkei R, Gratama JW, Rothe G et al. Performance of calibration standards for antigen quantitation with flow cytometry. Cytometry 1998; 33:188-96.
26. Strohmeyer JC, Blume C, Meisel C et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry 2003; 53B:54-62.
27. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
28. Wolk K, von Doecke WD, Volk H, Sabat R. Comparison of monocyte functions after LPS-or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology 1999; 67:253-6.
29. Fagny C, Marchant A, De Prez E, Goldman M, Deschodt-Lanckman M. Lipopolysaccharide induces upregulation of neutral endopeptidase 24.11 on human neutrophils: involvement of the CD14 receptor. Clin Sci (Lond) 1995; 89:83-9.
30. Ward PA, Lentsch AB. Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 2002; 234-235:225-8.
31. D'Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 2000; 1:387-91.
32. Nockher WA, Scherberich JE. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 1997; 158:1345-52.
33. Werfel T, Sonntag G, Weber MH, Goetze O. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991; 147:3909-14.
34. Dybkaer K, Olesen G, Pedersen FS, Kristensen JS. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients. Eur J Haematol 2001; 66:168-77.